{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-07T12:23:07.859393+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\" - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\"</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-04T22:23:35+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQWUxIaXlwSlVpNzl3dENLR2twY2FHU3Q1M09LNHJhVUdSX01wYUZGdzZjYmNCenpucUxkMUktb1VIUWtLR1UxNkdKdVg3VDJHSHJGWHhqNGhVUGRzMDJRbko1eHYwY3hxYmY2Z01DZlN2NmNIRktsaTdzSUl5WVhHaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWUxIaXlwSlVpNzl3dENLR2twY2FHU3Q1M09LNHJhVUdSX01wYUZGdzZjYmNCenpucUxkMUktb1VIUWtLR1UxNkdKdVg3VDJHSHJGWHhqNGhVUGRzMDJRbko1eHYwY3hxYmY2Z01DZlN2NmNIRktsaTdzSUl5WVhHaw?oc=5\" target=\"_blank\">Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-04T15:41:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Revenue Performance and Promising Prospects Justify Buy Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQakVlWlJFSzZzLV8zZ2VOVHg0Y2x2VW1wNXJ3X0RzTnludXN0enhNRkp4Wmc4dlVZeFEtQmU1QzZWSTk2SHdxVm80NFlMWDYzSVRBTHFnSDdEcmE2dW10X2lxaEd4a1J1UG1Ja1k0dVEyeWE0TDY3UEZjN0ZQNHlFZ3dDYjhPNE5ubXJOaXEwYlZ1N2dWM1hKejROandKb3l4LXRQcjh6bl9oRnkxQVRjYm16X2JOTTd3U1c3dnF4NHZibERVcXZ5VzNydEZaVjVpNDhvMg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQakVlWlJFSzZzLV8zZ2VOVHg0Y2x2VW1wNXJ3X0RzTnludXN0enhNRkp4Wmc4dlVZeFEtQmU1QzZWSTk2SHdxVm80NFlMWDYzSVRBTHFnSDdEcmE2dW10X2lxaEd4a1J1UG1Ja1k0dVEyeWE0TDY3UEZjN0ZQNHlFZ3dDYjhPNE5ubXJOaXEwYlZ1N2dWM1hKejROandKb3l4LXRQcjh6bl9oRnkxQVRjYm16X2JOTTd3U1c3dnF4NHZibERVcXZ5VzNydEZaVjVpNDhvMg?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Revenue Performance and Promising Prospects Justify Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-07T11:22:25+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Committee stocks on the move: Uber and Vertex Pharma - CNBC",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxONEd0bGRLUzZ3aVgyMHU2bEh1cmtkd2FwWEJFM0xpelpIamhCVzVsVGhXWU85eDZFZUpRMHNENk10VlZEU1BQbWh3MHVhNjY1c0E1X0ZqYUJDUVI0TzdhUDNBY2lsYkFPYVFoUGxiVkRBb2lKSGFjYmZQb1lHTzhTenZwOFhwT1Q3RW1nY0g1VHJWaGZPZmRyYTBn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxONEd0bGRLUzZ3aVgyMHU2bEh1cmtkd2FwWEJFM0xpelpIamhCVzVsVGhXWU85eDZFZUpRMHNENk10VlZEU1BQbWh3MHVhNjY1c0E1X0ZqYUJDUVI0TzdhUDNBY2lsYkFPYVFoUGxiVkRBb2lKSGFjYmZQb1lHTzhTenZwOFhwT1Q3RW1nY0g1VHJWaGZPZmRyYTBn?oc=5\" target=\"_blank\">Committee stocks on the move: Uber and Vertex Pharma</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-04T18:03:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3 - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5\" target=\"_blank\">Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-11-04T13:40:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "After pain setback, Vertex spotlights renal portfolio in expectation-beating Q3 - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWU2ZGNElLRnBuSW1iZmRpSndqRW82bmdveVlSYjNTSW9qR29CUHlJNlI0Z3BSWWlnY0Z0NnJFQzc4cktDakZnYWpRZ0xXc1NORGlr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWU2ZGNElLRnBuSW1iZmRpSndqRW82bmdveVlSYjNTSW9qR29CUHlJNlI0Z3BSWWlnY0Z0NnJFQzc4cktDakZnYWpRZ0xXc1NORGlr?oc=5\" target=\"_blank\">After pain setback, Vertex spotlights renal portfolio in expectation-beating Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-11-03T21:11:21+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T16:48:41+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T13:59:58+00:00",
      "source": "BioSpace"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T23:40:36+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Vertex Pharmaceuticals Reports Strong Q3 2025 Results - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Reports Strong Q3 2025 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-04T03:56:57+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-04T22:05:14+00:00",
      "source": "The Globe and Mail"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-06",
      "close": 416.25
    },
    "history": [
      {
        "date": "2025-10-29",
        "close": 417.2099914550781
      },
      {
        "date": "2025-10-30",
        "close": 419.8900146484375
      },
      {
        "date": "2025-10-31",
        "close": 425.57000732421875
      },
      {
        "date": "2025-11-03",
        "close": 426.0
      },
      {
        "date": "2025-11-04",
        "close": 421.6700134277344
      },
      {
        "date": "2025-11-06",
        "close": 416.25
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}